Green light for generic rival to Nexium
Indian company Ranbaxy has been given clearance to launch a generic rival to AstraZeneca’s gastrointestinal drug Nexium in the UK
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: